News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
365,852 Results
Type
Article (19349)
Company Profile (80)
Press Release (346418)
Multimedia
Podcasts (59)
Webinars (8)
Section
Business (95637)
Career Advice (1394)
Deals (18466)
Drug Delivery (58)
Drug Development (53994)
Employer Resources (66)
FDA (8928)
Job Trends (7494)
News (175543)
Policy (15090)
Tag
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1333)
Accelerated approval (38)
Adcomms (18)
Allergies (129)
Alliances (19927)
ALS (159)
Alzheimer's disease (1070)
Antibody-drug conjugate (ADC) (411)
Approvals (9408)
Artificial intelligence (456)
Autoimmune disease (255)
Automation (33)
Bankruptcy (141)
Best Places to Work (6347)
BIOSECURE Act (6)
Biosimilars (173)
Biotechnology (53)
Bladder cancer (186)
Brain cancer (62)
Breast cancer (681)
Cancer (4965)
Cardiovascular disease (389)
Career advice (1106)
Career pathing (21)
CAR-T (243)
CDC (25)
Celiac Disease (2)
Cell therapy (655)
Cervical cancer (36)
Clinical research (49683)
Collaboration (1477)
Company closure (5)
Compensation (995)
Complete response letters (57)
COVID-19 (2315)
CRISPR (79)
C-suite (706)
Cystic fibrosis (90)
Data (6951)
Decentralized trials (1)
Denatured (7)
Depression (120)
Dermatology (76)
Diabetes (440)
Diagnostics (4044)
Digital health (39)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (231)
Drug pricing (75)
Drug shortages (12)
Duchenne muscular dystrophy (231)
Earnings (57922)
Editorial (26)
Employer branding (8)
Employer resources (57)
Events (60226)
Executive appointments (700)
FDA (11905)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1222)
Gene editing (166)
Generative AI (29)
Gene therapy (524)
GLP-1 (741)
Government (2338)
Grass and pollen (6)
Guidances (384)
Healthcare (9642)
HIV (72)
Huntington's disease (47)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (98)
Immunology and inflammation (206)
Immuno-oncology (88)
Indications (161)
Infectious disease (2579)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (108)
Intellectual property (190)
Interviews (257)
IPO (10623)
IRA (20)
Job creations (1443)
Job search strategy (951)
JPM (29)
Kidney cancer (22)
Labor market (73)
Layoffs (314)
Leadership (27)
Legal (2706)
Liver cancer (79)
Longevity (16)
Lung cancer (684)
Lymphoma (392)
Machine learning (36)
Management (21)
Manufacturing (597)
MASH (183)
Medical device (6977)
Medtech (7065)
Mergers & acquisitions (8788)
Metabolic disorders (1156)
mRNA (127)
Multiple sclerosis (159)
NASH (18)
Neurodegenerative disease (331)
Neuropsychiatric disorders (89)
Neuroscience (2231)
NextGen: Class of 2026 (2750)
Non-profit (2315)
Now hiring (28)
Obesity (511)
Opinion (146)
Ovarian cancer (191)
Pain (199)
Pancreatic cancer (280)
Parkinson's disease (276)
Partnered (15)
Patents (364)
Patient recruitment (512)
Peanut (48)
People (21316)
Pharmaceutical (17)
Pharmacy benefit managers (14)
Phase 1 (13300)
Phase 2 (20783)
Phase 3 (20183)
Pipeline (7761)
Policy (116)
Postmarket research (1430)
Preclinical (4884)
Press Release (20)
Prostate cancer (268)
Psychedelics (30)
Radiopharmaceuticals (198)
Rare diseases (812)
Real estate (2017)
Recruiting (27)
Regulatory (13958)
Reports (38)
Research institute (1242)
Resumes & cover letters (263)
Rett syndrome (33)
RNA editing (19)
RSV (72)
Schizophrenia (152)
Series A (186)
Series B (149)
Service/supplier (7)
Sickle cell disease (89)
Special edition (26)
Spinal muscular atrophy (123)
Sponsored (27)
Startups (1550)
Stomach cancer (10)
Supply chain (75)
Tariffs (39)
The Weekly (52)
Vaccines (816)
Venture capital (73)
Weight loss (319)
Women's health (92)
Worklife (12)
Date
Last 7 days (577)
Last 30 days (2321)
Last 365 days (22605)
2026 (10748)
2025 (22749)
2024 (22755)
2023 (24262)
2022 (30419)
2021 (32440)
2020 (30716)
2019 (22462)
2018 (16988)
2017 (17765)
2016 (15578)
2015 (18285)
2014 (13409)
2013 (10256)
2012 (10942)
2011 (11481)
2010 (9882)
Location
Africa (429)
Alabama (44)
Alaska (3)
Arizona (119)
Arkansas (10)
Asia (24443)
Australia (4448)
California (10555)
Canada (2597)
China (1067)
Colorado (429)
Connecticut (475)
Delaware (343)
Europe (53316)
Florida (1225)
Georgia (309)
Hawaii (3)
Idaho (26)
Illinois (788)
India (60)
Indiana (417)
Iowa (12)
Japan (515)
Kansas (84)
Kentucky (19)
Louisiana (32)
Maine (47)
Maryland (1003)
Massachusetts (7206)
Michigan (152)
Minnesota (460)
Mississippi (6)
Missouri (103)
Montana (12)
Nebraska (9)
Nevada (113)
New Hampshire (51)
New Jersey (2722)
New Mexico (11)
New York (2542)
North Carolina (1185)
North Dakota (6)
Northern California (5409)
Ohio (275)
Oklahoma (10)
Oregon (24)
Pennsylvania (1866)
Puerto Rico (15)
Rhode Island (24)
South America (660)
South Carolina (39)
Southern California (4157)
Tennessee (120)
Texas (1599)
United States (34594)
Utah (224)
Virginia (244)
Washington D.C. (42)
Washington State (780)
West Virginia (2)
Wisconsin (123)
Wyoming (1)
365,852 Results for "3 v biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
May 7, 2026
·
6 min read
Press Releases
Jade Biosciences Announces Proposed Underwritten Public Offering - June 3, 2026
June 4, 2026
·
4 min read
Press Releases
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million
May 12, 2026
·
1 min read
Press Releases
Nielsen BioSciences Announces Positive Phase 3 Trial Results of CANDIN for the Treatment and Clearance of Common Warts
May 27, 2026
·
4 min read
Press Releases
InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities
May 20, 2026
·
3 min read
Press Releases
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
February 19, 2026
·
5 min read
Press Releases
Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma
June 1, 2026
·
5 min read
Press Releases
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May 7, 2026
·
9 min read
Press Releases
Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
May 4, 2026
·
8 min read
Press Releases
3T Biosciences Appoints Rebeca Villarreal-Barragan, MBA, as Head of Clinical Operations
March 2, 2026
·
2 min read
1 of 36,586
Next
